Perceptive Technologies
-55%
est. 2Y upside i
Automated tooth cutting for dentists using imaging, AI and robotics
Rank
#1695
Sector
Dental Technology, AI, Robotics
Est. Liquidity
~4Y
Data Quality
Data: LowPerceptive Technologies presents a moderate upside opportunity for a job seeker, driven by its innovative AI and robotic dental technology in a growing market.
Last updated: March 10, 2026
Perceptive Technologies achieves full FDA approval for its integrated robotic system and intraoral scanner, leading to rapid market adoption and significant partnerships with major DSOs. Revenue scales to over $150M by 2028, justifying a $600M+ valuation at a premium multiple due to its disruptive technology and strong competitive moat.
Perceptive successfully commercializes its intraoral scanner and gains initial traction with its robotic system, securing partial FDA approvals and expanding its customer base. Revenue reaches $50M by 2028, leading to an acquisition or later-stage funding round at a $250M-$300M valuation, reflecting steady growth and continued regulatory progress.
Regulatory hurdles for the full robotic system prove more challenging than anticipated, delaying widespread commercialization. Competitors, including established dental equipment manufacturers or well-funded AI diagnostics firms, introduce similar solutions, eroding Perceptive's market share. The company struggles to raise subsequent funding rounds, leading to a down round or distressed acquisition, wiping out most common stock value.
Preference Stack Risk
highInvestors hold approximately $47M in liquidation preferences, representing 27.6% of the estimated $170M current valuation.
Dilution Risk
moderateAs a Series B company with high capital intensity, at least one to two more significant funding rounds are likely needed before an exit, leading to further dilution.
Secondary Liquidity
noneThere are no active secondary markets or tender offers for this early-stage private company's equity.
Questions to Ask at the Interview
Strategic questions based on Perceptive Technologies's data — designed to show you've done your homework.
- 1
“Given the ongoing FDA approval process for the full robotic system, what are the key milestones and timelines the company is focused on over the next 12-24 months to achieve commercial readiness and widespread market adoption?”
- 2
“With a strong competitive moat in integrated AI and robotics, how does Perceptive plan to defend against potential moves by large dental equipment incumbents or well-funded AI diagnostic competitors like Overjet?”
- 3
“Considering the Series B funding and high capital intensity, what is the anticipated timeline for the next funding round, and how is the company thinking about employee equity and potential liquidity events for common shareholders?”
Community
Valuation Sentiment
Our model estimates -55% upside. What do you think?
Anonymous. Do not share material non-public information.
Community Discussion
Comments are reviewed before they appear publicly.
Loading comments...
Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.